Skip to main content
RapidAI logo

RapidAI

San Mateo, California, United StatesSee on the mapFounded 2011

  • Series C

RapidAI develops clinically validated AI-powered medical imaging and care coordination solutions for healthcare providers. Its enterprise platform analyzes and tracks imaging findings across clinical workflows to support decision-making, collaboration, and patient care.

Open roles
3
Posted last 30 days
2
Raised
$134M
Feb 2026
Series C
Investors
2

reccy insights

Recent highlights

RapidAI’s clearest recent financing milestone is a $25 million debt round dated Aug 14, 2026, with the investors undisclosed. Earlier, the company raised a reported $75 million Series C on Jul 27, 2023, with Vista Equity Partners and Vista Credit Partners named across its financing details. The company develops AI-assisted neurovascular imaging and care coordination tools for clinicians treating stroke and related conditions. Its product family includes Rapid NCCT, Rapid LVO, Rapid ICH, Rapid CTP, Rapid MRI and Rapid CTA, alongside RapidAI Insights and Navigator Pro. The available company information does not identify dated product launches, partnership announcements, awards or executive appointments, so no such milestones are asserted here. Financing details also include two entries dated Feb 17, 2026—an Early Stage VC entry with no amount and a Series C entry for $9,007,336—which should be treated cautiously because their relationship to one another is unclear. Overall, the clearest documented developments are financing events and the breadth of RapidAI’s imaging and workflow product portfolio.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

Open roles3

What makes RapidAI distinct

  1. 01Clinical validation and research underpin its AI-driven imaging insights.
  2. 02The platform is designed to fit into healthcare systems and workflows already in use.
  3. 03The company has expanded from stroke imaging into cardiovascular, endovascular, aneurysm and trauma applications.
  4. 04Its technology supports care-team coordination and access to specialists across locations.
  5. 05Rapid imaging was used in clinical trials associated with extending the stroke treatment window from 6 to 24 hours.

Technology & products8

  • Rapid Enterprise Platform
  • Rapid NCCT
  • Rapid LVO
  • Rapid Enterprise Platform
  • Rapid stroke imaging solutions, including Rapid NCCT, Rapid LVO, Rapid ICH, Rapid CTP, Rapid MRI and Rapid CTA
  • RapidAI Insights
  • Navigator Pro
  • Edge Cloud platform
  • Lumina 3D

Research roots1

Labs and research groups this company came from or works with.

  • Stanford UniversityStanford, United States · No page yet
    Founder affiliation
Academic data: Carter Sciences

Funding

$134M disclosed
  • DebtAug 2026
    $25MLed by Undisclosed Investors
  • Early Stage VCFeb 2026
  • Series CFeb 2026
    $9M
2 investors

About RapidAI

Products
Rapid Enterprise Platform, Rapid NCCT, Rapid LVO, Rapid ICH, Rapid CTP, Rapid MRI, Rapid CTA, RapidAI Insights
Leadership
Karim KartiRoland BammerCharles DickonsKhoa Pham
Focus areas
NeuroTechnology, digital health, AI/ML, diagnostics, healthcare AI, medical imaging, clinical decision support, care coordination
Headquarters
San Mateo, California, United States
Founded
2011
Employees
51–200
Status
Active · private